1340 related articles for article (PubMed ID: 16889069)
1. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
2. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
Han Y; Tian H; He P; Chen X; Jing X
Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
[TBL] [Abstract][Full Text] [Related]
3. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles.
Shi K; Cui F; Yamamoto H; Kawashima Y
Pharmazie; 2008 Dec; 63(12):866-71. PubMed ID: 19177901
[TBL] [Abstract][Full Text] [Related]
4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
5. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
6. Novel approach for delivery of insulin loaded poly(lactide-co-glycolide) nanoparticles using a combination of stabilizers.
Kumar PS; Saini TR; Chandrasekar D; Yellepeddi VK; Ramakrishna S; Diwan PV
Drug Deliv; 2007 Nov; 14(8):517-23. PubMed ID: 18027181
[TBL] [Abstract][Full Text] [Related]
7. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
8. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
9. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
11. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
12. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
13. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
He W; Horn SW; Hussain MD
Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
[TBL] [Abstract][Full Text] [Related]
14. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
Bozdag S; Dillen K; Vandervoort J; Ludwig A
J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
16. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
17. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
18. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
[TBL] [Abstract][Full Text] [Related]
19. Alginate microspheres prepared by internal gelation: development and effect on insulin stability.
Silva CM; Ribeiro AJ; Figueiredo IV; Gonçalves AR; Veiga F
Int J Pharm; 2006 Mar; 311(1-2):1-10. PubMed ID: 16442757
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]